Evidence map›Paper›PMID 38567475›Full record

ArticleLa Tunisie medicale2024

Prognostic value of preoperative diffusion restriction in glioblastoma.

Emna Labbène, Maha Mahmoud, Linda Marrakchi-Kacem, Mohamed Ben Hamouda

Abstract read
In one paragraph

Article in La Tunisie medicale, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emna LabbèneDepartment of radiology, MT Kassab institute of orthopaedics, Tunis, Tunisia.
Maha MahmoudFaculty of medicine of Tunis, Tunis-El Manar University, Tunis, Tunisia.
Linda Marrakchi-KacemHigher institute of biotechnology of Sidi Thabet, Manouba University, Tunis, Tunisia.
Mohamed Ben HamoudaFaculty of medicine of Tunis, Tunis-El Manar University, Tunis, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough glioblastoma (GBM) has a very poor prognosis, overall survival (OS) in treated patients shows great difference varying from few days to several months. Identifying factors explaining this difference would improve management of patient treatment.

aimTo determine the relevance of diffusion restriction in newly diagnosed treatment-naïve GBM patients.

methodsPreoperative magnetic resonance scans of 33 patients with GBM were reviewed. Regions of interest including all the T2 hyperintense lesion were drawn on diffusion weighted B0 images and transferred to the apparent diffusion coefficient (ADC) map. For each patient, a histogram displaying the ADC values within in the regions of interest was generated. Volumetric parameters including tumor regions with restricted diffusion, parameters derived from histogram and mean ADC value of the tumor were calculated. Their relationship with OS was analyzed.

resultsPatients with mean ADC value < 1415x10-6 mm2/s had a significantly shorter OS (p=0.021). Among volumetric parameters, the percentage of volume within T2 lesion with a normalized ADC value <1.5 times that in white matter was significantly associated with OS (p=0.0045). Patients with a percentage>23.92% had a shorter OS. Among parameters derived from histogram, the 50th percentile showed a trend towards significance for OS (p=0.055) with patients living longer when having higher values of 50th percentile. A difference in OS was observed between patients according to ADC peak of histogram but this difference did not reach statistical significance (p=0.0959).

conclusionDiffusion magnetic resonance imaging may provide useful information for predicting GBM prognosis.

Indexed as

Brain NeoplasmsGlioblastomaDiffusion Magnetic Resonance ImagingHumansMagnetic Resonance ImagingPrognosisRetrospective StudiesGlioblastomaImaging diffusion MRIMagnetic resonance imagingPrognosis

Identifiers

PMID38567475
PMCPMC11358806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.